Safety and Effectiveness of Addition of Maraviroc to ART Regimens in HIV-Infected Adults With Suboptimal CD4 T-Cell Count Recovery Despite Sustained Virologic Suppression

This study is currently recruiting participants.

Study NCT00709111 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: July 1, 2008 Last Updated: February 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)